Log In
BCIQ
Print this Print this
 

PHE377

  Manage Alerts
Collapse Summary General Information
Company PharmEste
DescriptionTransient receptor potential vanilloid 1 (TRPV1; VR1) antagonist
Molecular Target Transient receptor potential vanilloid 1 (TRPV1) (VR1)
Mechanism of ActionTransient receptor potential vanilloid 1 (TRPV1) (VR1) agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationPain
Indication DetailsTreat neuropathic pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today